Weigh vaccine carefully
An interesting opinion from Canada.
As a father of three daughters I have certainly taken notice of the announcement and promotion of a vaccine to treat the human papilloma virus. This virus has a strong connection to and may be the largest factor in the cause of cervical cancer.
Statistically, most women will become infected in their lifetime, 80 percent by some estimates.
But there is preliminary talk of making this vaccination mandatory for our school-aged daughters in the 11- to 16-year-old bracket. I'm afraid I must protest.
A MUSLIM doctors’ leader has provoked an outcry by urging British Muslims not to vaccinate their children against diseases such as measles, mumps and rubella because it is “un-Islamic”.
A patch which delivers a vaccine against Alzheimer's disease through the skin has been shown to be safe and effective, a study has found.
Allergen immunotherapy is a powerful and effective treatment option for patients with allergic rhinitis, allergic asthma, and allergy to stinging insects. Allergen immunotherapy (ie, "allergy shots") has been used for nearly 100 years, and has been shown to provide both short-term and often long-term relief from allergic symptoms. It may also help prevent the development of asthma, and may reduce the incidence of new allergic sensitivities. Creticos and colleagues evaluated an experimental alternative to the traditional approach to immunotherapy.
In the summer, it was announced that authorities in Scotland were considering vaccinating girls as young as 9 years old against the sexually transmitted human papilloma virus in order to combat the cervical cancer that can result from infection, but complaints from parents have stopped the plan in its tracks.
Mutations in the bird flu virus have been found in two infected people in Egypt, in a form that might be resistant to the medication most commonly used to treat the deadly disease, the World Health Organization said Thursday.
WASHINGTON - The government awarded contracts Wednesday to three drug makers tasked with developing a vaccine for bird flu using technology that will help stretch the supply of the medicine.
BASEL (AFX) - Novartis AG said it has received a contract from the US health department worth approximately 55 mln usd to further develop a novel antigen technology that could extend vaccine supplies in a pandemic outbreak.